Search

Your search keyword '"Jacobson, Ira"' showing total 1,280 results

Search Constraints

Start Over You searched for: Author "Jacobson, Ira" Remove constraint Author: "Jacobson, Ira"
1,280 results on '"Jacobson, Ira"'

Search Results

151. Intrahepatic CD4 (super +) cell depletion in hepatitis C virus/HIV-co infected patients

152. Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

153. Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options

154. Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial

159. Discovery and Development of Telaprevir

164. Futility rules in telaprevir combination treatment

165. Sustained virologic response (SVR) in prior peginterferon/ribavirin (PR) treatment failures after retreatment with boceprevir (BOC) + PR: the provide study interim results

171. Once Daily Sofosbuvir (GS-7977) plus PEG/RBV: High Early Response Rates Are Maintained During Post-Treatment Follow-Up In Treatment-Naïve Patients With HCV Genotype 1, 4, and 6 Infection in the ATOMIC Study: 230

173. Safety and efficacy of ritonavir-boosted danoprevir (DNVr), peginterferon α-2a (40KD) (P) and ribavirin (R) with or without mericitabine in HCV genotype (G)1-infected treatment-experienced patients with advanced hepatic fibrosis: 82

174. Up to 100% SVR4 rates with ritonavir-boosted danoprevir (DNVr), mericitabine (MCB) and ribavirin (R) ± peginterferon alfa-2a (40KD) (P) in HCV genotype 1-infected partial and null responders: results from the MATTERHORN study: 81

180. Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

182. Boceprevir for Untreated Chronic HCV Genotype 1 Infection

183. Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donors

184. Machine learning identifies histologic features associated with regression of cirrhosis in treatment for chronic hepatitis B

185. Antiviral activity and safety of the hepatitis B core inhibitor ABI-H0731 administered with a nucleos(t)ide reverse transcriptase inhibitor in patients with HBeAg-positive chronic hepatitis B infection in a long-term extension study

186. Antiviral activity and safety of the hepatitis B core inhibitor ABI-H0731 administered with a nucleos(t)ide reverse transcriptase inhibitor in patients with HBeAg-negative chronic hepatitis B infection

190. Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy

197. Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients

Catalog

Books, media, physical & digital resources